September 2021—Qiagen announced a commercialization partnership with Verogen that will provide customers with tools and comprehensive support for human identification workflows in laboratories.
The deal enables Qiagen to offer Verogen’s HID sequencing and analysis solutions that run on MiSeq FGx sequencers from Illumina. The agreement grants Qiagen the rights to distribute Verogen’s portfolio, including kits based on the Verogen ForenSeq assay, the Verogen MiSeq FGx sequencing system, and the Universal Analysis software, and covers an expansion of the partnership for future ForenSeq-based assays.
The two companies will also commercialize a menu of forensically validated workflows for next-generation sequencing that combine Verogen’s library-prep products with Qiagen’s QIAseq products and automation solutions.